Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveXiAn Eswin Material Technology Reports Q3 Net Profit of 440.7 Million Yuan

Live News EQUITY FLASH M impact Oct 19, 2026, 11:18 AM UTC

XiAn Eswin Material Technology Reports Q3 Net Profit of 440.7 Million Yuan

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

688783

Related stories

EyePoint to Cut 53% of Workforce After Trial Failure EyePoint said it would stop studies of its experimental age-related vision disease drug after a second late-stage trial failed. Its shares fell more than 75% in premarket trading. H impact | EQUITY | Oct 19, 2026, 12:19 PM UTC Metis TechBio and Eli Lilly Form Discovery Collaboration Potentially Worth Over $1 Billion The companies will work to discover lipid nanoparticle-based delivery solutions designed to enable tissue-specific delivery. M impact | EQUITY | Oct 19, 2026, 12:09 PM UTC Premarket movers: IRON reports Phase 3 trial success; EQPT raises outlook IRON said its pivotal Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints. CLF reported earnings; EQPT raised its 2026 financial outlook, citing performance M impact | EQUITY | Oct 19, 2026, 12:08 PM UTC Microsoft says withdrawal decision relates to a single site The statement was attributed to The New York Times. L impact | EQUITY | Oct 19, 2026, 12:08 PM UTC Johnson & Johnson reports 48-week Tremfya fistula-remission data The company says new data show Tremfya (guselkumab) delivered durable fistula remission through 48 weeks in Crohn’s disease patients with perianal fistula, describing it as the onl L impact | EQUITY | Oct 19, 2026, 12:08 PM UTC Phathom Pharmaceuticals Schedules Q3 2026 Results Call Phathom Pharmaceuticals will report third-quarter 2026 financial results and provide a business update by webcast on Oct. 29, 2026, at 8:00 a.m. EDT. M impact | EQUITY | Oct 19, 2026, 12:07 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.